https://www.dailyhealthindustry.it/bayer-fda-concede-nda-e-priority-review-a-larotrectinib/ 2018-06-08T13:46:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-futuro-roseo-in-cina-con-i-glp1/ 2018-06-10T16:01:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-camera-dei-rappresentanti-convoca-iarc-sul-tavolo-il-caso-glifosato-monsanto/ 2018-06-08T15:21:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emergent-biosolutions-vaccini-per-1-mld-di-dollari/ 2018-06-08T15:40:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-nuova-class-action-in-missouri/ 2018-06-10T20:45:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tribunale-torino-regioni-possono-abbassare-prezzo-farmaci-se-arriva-equivalente-piu-economico/ 2018-06-10T19:57:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-fondo-private-equity-acquisisce-envision-healthcare/ 2018-06-11T10:35:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-ricerca-vincolata-ad-approvazione-governo-preoccupazione-tra-le-pharma/ 2018-06-11T10:53:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fidia-completa-lacquisizione-di-sooft/ 2018-06-11T13:29:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-ok-nice-per-keytruda-nel-tumore-al-polmone/ 2018-06-11T13:46:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-buoni-risultati-per-atogepant-emicrania/ 2018-06-11T14:06:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melazzini-per-aifa-lavoro-quotidiano-e-dare-risposta-ai-pazienti/ 2018-06-11T15:40:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-nuovi-criteri-per-lo-smaltimento-dei-medicinali/ 2018-06-12T12:36:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/grunenthal-italia-aldo-sterpone-nuovo-gm-e-ad/ 2018-06-12T12:43:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stryker-su-boston-scientific/ 2018-06-12T13:41:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ecco-nant-sviluppera-oncologici-sperimentali-il-fondatore-e-patrick-soon-shiong/ 2018-06-12T16:06:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-e-astrazeneca-abbandonano-lanabecestat-alzheimer/ 2018-06-12T14:34:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-start-up-oncologies-parte-in-cina-e-stati-uniti/ 2018-06-12T16:04:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sun-pharma-torna-a-produrre-per-gli-usa/ 2018-06-13T12:08:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-lascia-il-responsabile-mondiale-dei-vaccini/ 2018-06-13T12:24:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nella-ue-restrizioni-al-valproato-in-gravidanza/ 2018-06-13T12:54:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ad-abiogen-il-premio-eccellenza-in-sanita/ 2018-06-14T12:39:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter-italia-premiata-per-la-dialisi-peritoneale-automatizzata-a-smau-bologna/ 2018-06-14T12:54:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-nel-2024-leadership-a-gsk-msd-sanofi-e-pfizer/ 2018-06-14T16:29:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/consip-aggiudicato-accordo-quadro-per-i-farmaci-biologici/ 2018-06-14T13:54:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-alla-ministra-grillo-serve-semplificazione-governance-pronti-al-dialogo/ 2018-06-14T15:17:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ocrelizumab-conferma-i-dati-a-lungo-termine-nella-sm/ 2018-06-14T15:18:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assogenerici-crescita-nel-primo-trimestre-2018/ 2018-06-15T12:22:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-da-ce-a-tagrisso-monoterapia-in-prima-linea-nel-tumore-al-polmone/ 2018-06-15T17:21:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/premio-letterario-merck-carl-safina-vince-la-16a-edizione/ 2018-06-15T13:15:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allegan-cambiamenti-nel-board-arriva-thomas-freyman-veterano-di-abbott/ 2018-06-15T14:49:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibiotico-resistenza-redatto-piano-ue/ 2018-06-15T14:48:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-baricitinib-centra-obiettivo-nel-les-a-meta-trial/ 2018-06-19T13:57:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-stop-a-studio-fremanezumab/ 2018-06-18T12:04:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-opdivo-alla-conquista-del-mercato-cinese/ 2018-06-18T16:49:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-bene-zessly-ed-erelzi/ 2018-06-18T16:49:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/macron-welfare-insostenibile-urgono-riforme/ 2018-06-18T13:23:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nice-nega-placet-a-farmaco-contro-malattia-rara/ 2018-06-18T17:22:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dreadmed-ok-fda-a-nuovo-software-per-pompe-insulina/ 2018-06-18T14:57:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valeant-da-fda-stop-a-duobril/ 2018-06-19T14:09:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-reputation-i-consumatori-premiano-la-governance/ 2018-06-19T14:22:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-evotec-la-regia-della-bu-malattie-infettive-di-sanofi/ 2018-06-19T14:45:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-pfizer-buoni-risultati-a-due-anni-per-bavencio/ 2018-06-19T15:21:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-acquisisce-foundation-medicine/ 2018-06-19T17:00:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-lancia-i-piani-light-di-assicurazione-sanitaria/ 2018-06-19T17:16:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ptp-roche-risdiplam-funziona-nella-popolazione-pediatrica/ 2018-06-20T16:04:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-uk-nhs-finanziato-con-soldi-risparmiati-dalla-brexit/ 2018-06-20T13:42:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pasteur-premiazione-primo-hackathon-e-contest-sulla-comunicazione-dei-vaccin/ 2018-06-20T14:21:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cannes-lions-health-al-via-la-quinta-edizione/ 2018-06-20T14:42:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-confermati-scaccabarozzi-e-cdp-per-biennio-2018-2020/ 2018-06-20T15:27:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-settimana-della-solidarieta-per-i-dipendenti-di-tutto-il-mondo/ 2018-06-20T15:13:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-e-nutrizione-nasce-nuovo-canale-dedicato/ 2018-06-21T08:55:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dompe-ampliato-il-sito-de-laquila/ 2018-06-21T12:40:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-bimatoprost-sr-raggiunge-obiettivi-clinici/ 2018-06-21T12:51:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-scommette-ancora-sulla-fibrosi-cistica/ 2018-06-21T13:03:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/berkshire-jp-morgan-e-amazon-il-nuovo-ceo-e-atul-gawande/ 2018-06-21T14:24:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pasterur-ecco-i-vincitori-del-contest-sui-vaccini/ 2018-06-24T09:22:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cvc-capital-partners-3-mld-di-euro-per-entrare-in-recordati/ 2018-06-24T15:21:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-2018-fuga-dei-top-manager-verso-le-start-up-biotech/ 2018-06-22T15:17:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scaccabarozzi-produzione-record-presto-italia-superera-germania/ 2018-06-22T15:27:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-fda-estende-uso-cinryze/ 2018-06-24T09:43:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/connessi-flessibili-imprenditori-i-medici-millennial-ritratti-da-sanofi/ 2018-06-24T10:18:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eidos-therapeutics-oltre-106-mln-di-dollari-di-ipo/ 2018-06-24T10:20:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-per-fda-combo-opdivo-yervoy-a-pazienti-con-elevato-tmb/ 2018-06-25T14:58:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-cosentyrx-nuove-indicazioni-di-efficacia-sulletichetta/ 2018-06-25T13:22:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-a-cannes-docu-film-in-bianco-e-nero-racconta-il-cancro/ 2018-06-25T13:45:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-fda-i-quattro-punti-dellaccordo/ 2018-06-25T14:08:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-derby-in-casa-semaglutide-orale-supera-victoza/ 2018-06-25T14:55:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-accordo-con-translate-bio-per-vaccini-a-mrna/ 2018-06-25T15:54:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ministro-grillo-al-via-rinnovo-commissioni-aifa/ 2018-06-26T10:11:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-e-boehringer-ingelheim-bene-jardiance-in-diabete-tipo-1/ 2018-06-26T10:39:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-la-domanda-per-shingrix-supera-lofferta/ 2018-06-26T13:35:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/uk-contor-lalzheimer-un-fondo-capital-venutre-da-350-mln-di-dollari/ 2018-06-26T14:01:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nuove-evidenze-per-combo-tecentriq-e-chemioterapia/ 2018-06-26T15:22:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-mavenclad-efficace-negli-over-50/ 2018-06-26T16:03:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-accordo-con-start-up-per-small-molecules-in-neurologia/ 2018-06-27T13:19:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/achaogen-fda-approva-zemdri-antibiotico-per-le-infezioni-urinarie/ 2018-06-27T13:34:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-toujeo-centra-endpoint-primario-in-studio-bright/ 2018-06-27T14:09:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genentech-roche-a-natale-antinfluenzale-di-nuova-generazione/ 2018-06-27T14:47:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gawande-la-cura-per-la-sanita-usa-e-chirurgica/ 2018-06-27T15:25:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/precision-biosciences-nuova-strada-per-le-terapie-car-t/ 2018-06-27T15:56:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cannes-lions-health-vince-la-creativita/ 2018-06-28T17:32:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/le-cinque-donne-doro-del-pharma/ 2018-06-28T13:59:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-cambia-pelle-nasce-spin-off-per-lhealthcare/ 2018-06-28T14:15:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-punta-sul-biologico-230-mln-di-euro-per-nuovo-sito/ 2018-06-28T14:31:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melanoma-ok-fda-a-combo-braftovi-mektovi/ 2018-06-28T14:42:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spectrum-in-vendita-per-2-mld-di-dollari/ 2018-06-28T15:10:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-da-chmp-doppia-raccomandazione-per-kymriah/ 2018-07-02T13:33:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-marchio-ce-per-mimimed-670-g/ 2018-07-02T13:48:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amazon-con-pillpack-entra-nella-distribuzione-dei-farmaci-da-prescrizione/ 2018-07-02T14:12:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-bene-xtandi-nello-studio-prosper/ 2018-07-02T14:51:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-evidenze-positive-per-suliqua/ 2018-07-02T15:02:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/puma-biotechnology-dopo-cinque-mesi-arriva-il-si-del-chmp-a-neratinib/ 2018-07-02T15:15:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-spin-off-di-alcon-entro-la-fine-del-2019/ 2018-07-03T10:43:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cvc-capital-partners-e-fatta-per-recordati/ 2018-07-03T12:45:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sifo-linee-guida-per-la-sicurezza-e-la-prevenzione-dei-furti-dei-farmaci/ 2018-07-03T13:02:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-bene-combo-tecentriq-chemio-nel-tumore-al-seno-metastatico/ 2018-07-03T13:31:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hard-brexit-i-piani-di-msd-e-sanofi/ 2018-07-03T13:47:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-700-mln-di-dollari-nella-jv-con-samsung-biologics/ 2018-07-03T14:17:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-deborah-dunsire-nuovo-ceo/ 2018-07-04T15:56:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-sfida-mylan-su-epipen/ 2018-07-04T12:47:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-via-libera-in-giappone-a-imfinzi-e-a-lynparza/ 2018-07-04T16:01:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fonti-pharma-awards-massimo-visentin-ceo-dellanno/ 2018-07-04T13:27:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-italia-azienda-certificata-iso-9001/ 2018-07-04T13:30:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-online-il-nuovo-sito-italiano/ 2018-07-04T15:53:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-rivoluzione-della-sanita-cinese-tra-alibaba-e-i-big-data/ 2018-07-05T13:28:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-it-e-monitoraggio-pazienti-per-catena-ospedaliera-americana/ 2018-07-05T13:46:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sunovion-funziona-candidato-contro-disturbi-motori-del-parkinson/ 2018-07-05T13:56:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/inovio-vaccino-mers-supera-la-fase-1/ 2018-07-05T14:05:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-online-un-questionario-per-valutarne-i-servizi/ 2018-07-05T14:37:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aspen-antitrust-chiude-procedimento-per-eccesso-prezzi-antitumorali/ 2018-07-05T15:08:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-a-cena-con-johnson-gsk-e-theresa-may-nel-menu-brexit-e-prezzi-farmaci/ 2018-07-06T13:13:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/effetto-shire-takeda-vende-sede-di-osaka/ 2018-07-06T13:42:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-cresce-lattesa-per-i-dati-su-filgotinib/ 2018-07-08T16:50:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/piazza-affari-chiama-il-pharma-italiano/ 2018-07-06T14:08:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-bene-candidato-alzheimer-bocciato-a-dicembre/ 2018-07-06T14:22:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-su-nejm-i-dati-di-cabozantinib-su-hcc/ 2018-07-06T15:45:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-da-aifa-ok-a-rimborsabilita-bezlotoxumab/ 2018-07-09T10:46:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/upsa-sul-mercato-nuova-cessione-nel-consumer-health/ 2018-07-09T13:00:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-la-questione-shingrix-arriva-al-senato-usa/ 2018-07-09T13:17:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-usa-trasloca-sito-unico-nel-new-jersey/ 2018-07-09T13:34:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-romosozumab-convince-nei-trial-ma-ancora-problemi-sicurezza/ 2018-07-09T14:03:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-premio-letterario-zanibelli-al-via-la-sesta-edizione/ 2018-07-09T16:00:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/md-rekeep-acquisisce-maggioranza-di-medical-device/ 2018-07-10T10:56:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-2018-gia-100-mld-di-dollari-in-ma/ 2018-07-10T12:24:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adv-digitale-nel-pharma-crescita-costante-ma-lenta/ 2018-07-10T14:05:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-nuova-spallata-allobamacare/ 2018-07-10T14:13:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nimbus-un-top-manager-gilead-per-scoprire-nuovi-farmaci/ 2018-07-10T14:43:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-italia-lancia-progetto-di-advocacy-digitale-in-oncologia/ 2020-11-10T09:16:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-sondaggio-ema-sui-prodotti-uk-a-rischio/ 2018-07-11T11:03:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-italia-il-benessere-parte-dai-dipendenti/ 2018-07-11T13:00:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-michael-amoruso-a-capo-di-kite-avra-la-regia-di-yescarta/ 2018-07-11T13:07:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-trump-vicenda-conclusa/ 2018-07-11T13:31:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-dispositivo-indossabile-rileva-la-fibrillazione-atriale/ 2018-07-11T14:48:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-italia-primo-produttore-di-farmaci-in-europa/ 2018-07-11T15:15:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ecco-la-nuova-organizzazione/ 2018-07-12T10:10:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-ok-fda-a-combo-opdivo-yervoy-nei-tumori-rari-del-colon/ 2018-07-12T10:43:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-partnership-con-4d-molecular-per-terapie-aav/ 2018-07-12T10:49:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-rapporto-nazionale-farmaci-2017-la-foto-dellitalia/ 2018-07-12T13:28:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-nuovo-sito-in-europa-per-la-salute-veterinaria/ 2018-07-12T16:05:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/painreform-ok-fda-a-studi-su-analgesico-non-oppiaceo/ 2018-07-12T16:12:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-caso-talco-da-corte-di-st-louis-condanna-per-469-mld-di-dollari/ 2018-07-13T11:37:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-abbandona-la-ricerca-sugli-antibiotici/ 2018-07-13T12:29:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zogenix-successo-candidato-contro-forma-rara-di-epilessia/ 2018-07-13T12:43:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-storytelling-di-pazienti-per-le-terapi-oncologiche/ 2018-07-13T13:46:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-selezione-pubblica-per-il-nuovo-dg/ 2018-07-14T15:10:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-shopping-nel-biotech-e-nel-medical-device/ 2018-07-14T15:23:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-nasce-lasse-cina-india/ 2018-07-16T11:10:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-aifa-ad-atezolizumab-nel-nsclc/ 2018-07-16T12:10:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-accelera-sulla-car-t/ 2018-07-16T12:22:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-mentoring-peer-to-peer-per-pazienti-con-ipertensione-polmonare/ 2018-07-16T12:32:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-in-italia-nel-2017-spesa-aumentata-di-oltre-un-terzo/ 2018-07-16T12:53:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-programma-di-studi-clinici-per-tremfya-guselkumab/ 2018-07-16T15:24:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-ok-fda-a-mitraclip-di-terza-generazione/ 2018-07-17T10:34:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-accordo-da-oltre-140-milioni-di-euro-con-ospedali-tedeschi/ 2018-07-17T13:11:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-italia-primo-summer-camp-per-i-figli-dei-propri-dipendenti-e-collaboratori/ 2018-07-17T11:20:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-ipotesi-acquisizione-alexion/ 2018-07-17T11:20:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nextclinics-acquisisce-gruppo-gynepro/ 2018-07-17T13:56:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-ecco-la-linea-difensiva-per-lappello/ 2018-07-17T14:22:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bill-gates-lancia-addf-diagnostics-accelerator-per-la-diagnosi-precoce-di-alzheimer/ 2018-07-18T13:03:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-q2-piu-che-convincente/ 2018-07-18T11:04:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-report-trasparenza-pubblicati-54-dossier/ 2018-07-18T13:08:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-dal-primo-ottobre-al-via-lo-smart-working/ 2018-07-18T12:56:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-arriva-in-italia-sarilumab/ 2018-07-18T14:46:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-nuove-nomine-per-laccess-e-la-bu-oncology/ 2018-07-18T15:09:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-aumentare-numero-farmaci-senza-ricetta/ 2018-07-19T16:36:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nuove-evidenze-per-il-nuovo-antivirale-baloxavir-marboxil/ 2018-07-19T12:00:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-il-ceo-ci-crede-cina-secondo-mercato/ 2018-07-19T12:20:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-parlamentari-uk-votano-per-rimanere-nellema/ 2018-07-19T12:54:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-lilly-antidolorifico-tanezumab-centra-obiettivo-studio-fase-avanzata/ 2018-07-19T13:28:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-melazzini-accesso-pieno-ai-farmaci-innovativi/ 2018-07-19T13:40:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-abicipar-centra-obiettivo-in-due-studi/ 2018-07-20T12:55:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-tolvaptan-efficace-a-lungo-termine/ 2018-07-20T14:48:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-usa-gottlieb-striglia-le-pharma/ 2018-07-20T14:45:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-preso-candidato-contro-dermatite-atopica/ 2018-07-20T15:09:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-tecentriq-anche-nel-carcinoma-epatico/ 2018-07-20T15:35:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/presage-investe-su-fase-zero-degli-studi-clinici-celgene-e-takeda-ci-credono/ 2018-07-20T15:44:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-ema-assume-nuovi-funzionari-per-sostituire-i-britannici/ 2018-07-23T12:52:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/agios-fda-approva-primo-farmaco-e-tibsovo/ 2018-07-23T13:07:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-gilead-mani-sulla-biotech-olandese-gadeta/ 2018-07-23T15:43:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-usa-si-allineano-roche-bayer-e-merck-kgaa/ 2018-07-23T15:38:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomarin-un-musical-a-broadway-per-parlare-di-emofilia/ 2018-07-23T15:41:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-acquisisce-bu-oncologia-di-shire/ 2018-07-23T16:04:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-terza-breakthrough-therapy-per-tecentriq-stavolta-e-per-lhcc/ 2018-07-24T10:02:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-da-fine-anno-stop-al-contraccettivo-essure/ 2018-07-24T11:01:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-italia-piange-lex-ad-umberto-mortari/ 2018-07-24T13:31:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-eisai-candidato-alzheimer-convince-sempre-di-piu/ 2018-07-24T14:55:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-racconta-loncologia-in-una-app/ 2018-07-24T15:14:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-a-quando-lo-spin-offe-della-consumer/ 2018-07-24T15:40:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-punta-sulle-terapie-digitali-17-mln-di-dollari-a-start-up-click-therapeutics/ 2018-07-25T10:43:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-partnership-con-puretech-health-per-sviluppare-aso/ 2018-07-25T11:14:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-cresce-la-spesa-pharma-per-il-lobbyng/ 2018-07-25T12:05:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/federfarma-primo-trimestre-2018-cala-spesa-farmaceutica-ssn/ 2018-07-25T20:06:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-msd-patients-digital-health-award-online-il-bando/ 2020-11-10T08:24:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-combo-dolutegravir-lamivudina-supera-test-chiave/ 2018-07-25T15:15:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-italia-vincenzo-palermo-a-capo-della-unit-car-t/ 2018-07-26T10:42:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-si-assicura-due-candidati-per-le-malattie-neuromuscolari/ 2018-07-26T10:59:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-accordo-con-biotech-per-sviluppare-inibitori-sintesi-proteica/ 2018-07-26T16:38:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-q2-migliore-delle-previsioni-in-aumento-anche-le-stime-per-lanno/ 2018-07-26T14:24:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-accordo-con-banca-dati-genetica-per-rinforzare-la-pipeline/ 2018-07-26T15:17:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-e-amgen-i-dati-del-piu-vasto-real-world-dellemicrania/ 2018-07-26T15:56:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-q2-trascinato-dai-nuovi-farmaci/ 2018-07-27T10:50:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-vola-revlimid-nel-q2/ 2018-07-27T11:08:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-fda-a-orlissa/ 2018-07-27T12:15:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-il-futuro-del-business-passa-per-quattro-aree-terapeutiche/ 2018-07-27T12:50:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-arriva-in-italia-alectinib-tumore-al-polmone/ 2018-08-02T08:32:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melazzini-lascia-aifa-il-saluto-ai-dipendenti/ 2018-08-31T14:57:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-sbarca-nellotc-francese-con-acquisizione-nhco-nutrition/ 2018-09-03T10:32:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-una-ex-amgen-al-timone-delle-operazioni-commerciali/ 2018-09-03T10:49:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-due-nuovi-farmaci-per-lhiv/ 2018-09-03T16:31:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ok-da-ema-a-cablivi/ 2018-09-03T14:47:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-via-libera-fda-a-jivi/ 2018-09-03T15:03:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lautunno-caldo-di-ce-ed-ema/ 2018-09-03T15:42:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-la-soluzione-di-sanofi-per-i-vaccini-antinfluenzali/ 2018-09-04T08:39:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-cristopher-boerner-nuovo-commercial-chief-mondiale/ 2018-09-04T09:04:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/santhera-punta-tutto-su-raxone-nella-dmd/ 2018-09-04T15:40:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-accordo-e-investimento-azionario-in-genomics/ 2018-09-04T15:53:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sequirus-2018-doro-con-flucelvax-e-fluad/ 2018-09-04T16:02:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-leo-pharma-i-dermatologici-da-prescrizione-di-bayer/ 2018-09-04T16:04:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-100-mln-di-dollari-per-adeguarsi-alla-brexit/ 2018-09-05T10:40:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/berkshire-amazon-jp-morgan-jack-stoddard-e-il-nuovo-coo/ 2018-09-05T11:43:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomarin-si-espande-in-irlanda/ 2018-09-05T12:12:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-nuovo-investimento-in-toscana-a-uso-industriale/ 2018-09-05T12:28:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nupharm-jorg-thomas-dierks-e-il-nuovo-ceo/ 2018-09-05T12:53:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-e-luca-li-bassi-il-nuovo-direttore-generale/ 2018-09-05T15:20:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chi-med-lancia-primo-farmaco-biotech-made-in-china/ 2018-09-06T12:05:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ad-aurobindo-i-generici-per-via-orale-di-sandoz/ 2018-09-06T12:26:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-accordo-con-nhs-per-kymriah-in-uk/ 2018-09-06T12:29:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/litaliana-olon-si-espande-in-india-acquisito-sito-produttivo/ 2018-09-06T16:05:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-bene-il-q2-male-la-consumer-health/ 2018-09-06T15:40:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sutro-biopharma-85-mln-di-dollari-per-sviluppare-adc/ 2018-09-06T15:57:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-e-amgen-breakthrough-therapy-per-tezepelumab/ 2018-09-07T10:50:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-movimenti-strategici-nellarea-respiratoria/ 2018-09-07T16:12:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-presto-in-usa-il-primo-farmaco-digitale-per-la-schizofrenia/ 2018-09-07T16:11:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ozempic-vola-negli-spot-tv-usa/ 2018-09-07T15:37:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-punta-alla-leadership-preso-sun-direttore-vaccini-fda/ 2018-09-07T14:07:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fallisce-theranos-la-blood-testing-firm-della-silicon-valley/ 2018-09-07T15:02:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-accordo-con-piattaforma-francese-per-sviluppo-farmaci-dmd/ 2018-09-10T11:00:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-la-lunga-risalita-del-2018/ 2018-09-10T12:15:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-healthcare-apre-a-uppsala-il-tesla-center/ 2018-09-11T09:03:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-hiv-truvada-assunta-da-una-persona-su-nove/ 2018-09-10T14:27:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-da-ce-via-libera-a-combo-keytruda-chemioterapia/ 2018-09-10T15:13:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ok-anche-in-italia-a-dupilumab/ 2018-09-10T15:46:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boston-scientific-500-mln-di-dollari-per-augmenix/ 2018-09-11T13:04:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-ok-da-ce-a-nuovo-schema-per-aflibercept/ 2018-09-11T16:21:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-da-aifa-rimborsabilita-per-nivolumab-nei-tumori-testa-collo/ 2018-09-11T13:41:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-nuove-conferme-per-il-vaccino-anti-ebola/ 2018-09-11T14:19:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-cresce-limport-export-nella-ue/ 2018-09-11T14:46:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medivir-nuova-cmo-per-pipeline-oncologica/ 2018-09-11T15:21:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-pfizer-bene-combo-bavencio-inlyta-nel-tumore-del-rene/ 2018-09-12T19:48:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-pescatore-nuovo-vp-business-unit-oncology/ 2018-09-12T16:27:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mario-melazzini-nuovo-direttore-scientifico-di-ics-maugeri/ 2018-09-12T13:00:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-a-ginevra-il-nuovo-quartier-generale-di-alcon/ 2018-09-12T16:38:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-in-italia-arriva-cangrelor-nuovo-anticoagulante-venoso/ 2018-09-12T14:53:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-ce-approva-estensione-blincyto-a-pazienti-pediatrici-con-lla/ 2018-09-12T15:21:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-vende-la-bu-oftalmica-di-shire/ 2018-09-13T11:09:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-contest-mondiale-per-prevenzione-cancro-polmoni/ 2018-09-13T13:44:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-raddoppia-nuovo-stabilimento-negli-usa/ 2018-09-13T13:58:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dg-aifa-ok-dalla-stato-regioni-a-luca-li-bassi/ 2018-09-13T16:48:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/apple-lancia-lo-smartwatch-con-lecg-via-libera-da-fda/ 2018-09-13T15:42:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-fingolimod-riduce-tasso-recidive-nei-giovani-con-sm/ 2018-09-13T16:23:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-fa-shopping-nellimmuno-oncologia/ 2018-09-14T12:29:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-fda-a-lumoxiti/ 2018-09-14T12:38:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-anche-roche-preoccupata-per-i-rischi/ 2018-09-14T13:47:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-bayer-incrocio-di-dirigenti/ 2018-09-14T14:03:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-la-unit-medis-piace-al-mercato/ 2018-09-14T14:31:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nuovi-dati-real-world-a-favore-di-cosentyx/ 2018-09-14T15:36:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-chiara-gargiulo-vice-president-bu-respiratory/ 2018-09-17T12:21:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-accordo-con-deloitte-per-uniformare-i-big-data-dei-trattamenti/ 2018-09-17T12:27:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-acquista-candidato-rivale-di-botox/ 2018-09-17T12:52:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-e-arrivato-lok-fda-a-fremanezumab/ 2018-09-17T15:29:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allogene-la-biotech-car-t-da-100-mln-di-ipo/ 2018-09-17T15:41:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-stress-test-per-humira-a-ottobre-in-europa-i-primi-biosimilari/ 2018-09-17T16:09:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-futuro-roseo-con-i-nuovi-farmaci/ 2018-09-18T12:09:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-avanti-tutta-sul-vaccino-pneumococcico-20-valente/ 2018-09-18T15:58:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotronik-ok-fda-a-stent-di-emergenza/ 2018-09-18T13:51:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-brandicourt-obiettivo-riduzione-costi-raggiunto/ 2018-09-18T15:01:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-arriva-in-italia-ustekinumab/ 2018-09-18T16:43:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assogenerici-quota-di-mercato-dei-biosimilari-in-doppia-cifra/ 2018-09-18T16:28:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alibaba-chip-e-ia-anche-per-il-settore-sanitario/ 2018-09-19T12:39:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-la-strategia-per-conquistare-la-cina/ 2018-09-19T12:52:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-per-il-diabete-risponde-sofia/ 2018-09-19T13:21:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viking-therapeutics-ottimi-risultati-per-il-candidato-nash/ 2018-09-19T15:13:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-italia-ecco-il-sito-ragazzi-coraggiosi-per-la-malattia-di-chron/ 2018-09-19T15:21:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-del-nice-a-combo-tafinlar-mekinist/ 2018-09-19T15:51:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-ipo-su-elanco-e-volano-le-azioni/ 2018-09-20T12:44:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nestle-skin-health-in-vendita/ 2018-09-20T12:53:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-bonus-ai-dipendenti-che-rispettano-comportamento-etico/ 2018-09-20T13:38:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-chris-corsico-nuovo-cmo/ 2018-09-20T13:58:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-dati-real-world-confermano-efficacia-esbriet/ 2018-09-20T16:08:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-via-libera-da-ce-a-hulio-biosimilare-di-humira/ 2018-09-20T16:31:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-partnership-scientifiche-per-salvare-la-ricerca-canche-litalia/ 2018-09-21T12:51:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-chmp-dice-si-a-cabozantinib/ 2018-09-21T12:50:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aurobindo-accordo-da-un-mld-di-dollari-con-novartis/ 2018-09-21T12:49:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-su-mazor-robotics/ 2018-09-21T14:48:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pierre-fabre-ok-ce-a-combo-encorafenib-binimetinib/ 2018-09-21T14:56:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-chmp-a-luxturna/ 2018-09-21T15:56:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-punta-sulla-california-con-biola/ 2018-09-24T11:09:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-via-libera-dal-chmp-a-alunbrig/ 2018-09-24T12:03:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-doppio-si-per-jivi-in-europa-e-in-giappone/ 2018-09-24T12:04:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-settimana-decisiva-per-emgality/ 2018-09-24T12:15:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-un-hub-di-medicina-estetica-per-conquistare-il-mercato-asiatico/ 2018-09-24T13:28:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-breakthrough-therapy-per-vaccino-pneumococcico-20-valente/ 2018-09-24T15:02:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-msd-italia-il-premio-nostalgia-di-futuro-2018/ 2018-09-25T10:53:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-pronto-test-sangue-che-identifica-70-mutazioni-genetiche-del-tumore/ 2018-09-25T13:11:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-da-ce-via-libera-a-imfinzi/ 2018-09-25T13:22:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-a-gennaio-in-usa-i-generici-di-harvoni-ed-epclusa/ 2018-09-25T15:12:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/entera-bio-il-nuovo-cmo-arriva-da-msd/ 2018-09-25T15:24:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-domanda-per-ranibizumab-nel-trattamento-della-rop/ 2018-09-25T16:10:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-chmp-a-combo-venclyxto-rituximab-nella-llcr/ 2018-09-26T11:01:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-presentato-a-milano-libro-bianco-sulla-sma/ 2018-09-26T12:51:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-nel-2024-novartis-al-top-delle-vendite/ 2018-09-26T12:58:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-funziona-il-candidato-vaccino-contro-la-tubercolosi/ 2018-09-26T14:01:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-durvalumab-migliora-os-nel-tumore-al-polmone-di-fase-iii/ 2018-09-26T15:07:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-nuova-pubblicita-guarda-ai-millennial/ 2018-09-26T16:47:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiotec-riformare-la-governance-farmaceutica/ 2018-09-27T13:09:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-in-usa-torna-flumist-vaccino-antinfluenzale-spray/ 2018-09-27T13:30:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-oltre-un-mld-di-dollari-per-synthimmune/ 2018-09-27T14:16:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-cauto-ottimismo-da-ue-ed-ema/ 2018-09-27T15:48:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-e-allarme-violazione-dati-sanitari/ 2018-09-27T15:57:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-a-canakinumab-menzione-speciale-del-prix-galien-italia-2018/ 2018-09-27T16:07:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-in-gb-vola-nonostante-lo-spettro-brexit/ 2018-09-28T10:06:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-a-januvia-il-prix-galien-italia-2018/ 2018-09-28T10:33:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-accordo-con-cellular-biomedicine-per-produrre-kymriah-in-cina/ 2018-09-28T13:17:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-sebastian-guth-alla-guida-di-usa-e-america-latina/ 2018-09-28T13:36:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/blueprint-primi-risultati-della-combo-con-tagrisso-nel-nsclc/ 2018-09-28T14:15:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-nuovo-look-per-il-sito-web/ 2018-09-30T09:58:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-da-fda-via-libera-a-vizimpro/ 2018-10-01T12:13:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-per-emgality-ok-anche-dalla-fda/ 2018-10-01T12:29:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-first-to-file-per-generico-di-cialis/ 2018-10-01T14:26:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-19-mln-di-dollari-da-cepi-per-produrre-vaccini/ 2018-10-01T14:49:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-regeneron-ok-fda-a-libtayo/ 2018-10-02T09:54:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allarme-corte-dei-conti-troppo-vecchi-mammografi-tc-e-rmn/ 2018-10-01T16:14:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-read-lascia-da-gennaio-albert-bourla-nuovo-ceo/ 2018-10-02T11:00:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-innovative-immunotherapy-alliance-jv-tra-usa-e-cuba/ 2018-10-02T12:22:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-nel-q1-2019-sul-mercato-le-penne-intelligenti-per-insulina/ 2018-10-02T12:49:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boston-scientific-ok-fda-a-stent-eluvia/ 2018-10-02T15:16:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/premio-ggi-merck-ce-anche-una-ricercatrice-italiana/ 2018-10-02T15:35:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gamida-cell-ipo-al-nasdaq-per-terapie-cellulari-in-ematologia/ 2018-10-02T16:14:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-premio-zanibelli-2018-ecco-i-vincitori/ 2018-10-03T10:51:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-arriva-in-italia-ocrelizumab/ 2018-10-03T11:06:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-usa-occhio-a-queste-15/ 2018-10-03T11:28:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-boehringer-ingelheim-maurizio-sartorato-nuovo-ad-di-bidachem/ 2018-10-03T12:16:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dnanexus-58-mln-di-dollari-per-portare-sul-cloud-il-genoma/ 2018-10-03T13:24:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-spin-off-dopo-monsanto/ 2018-10-03T15:52:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuova-bufera-sul-pharma/ 2018-10-03T17:07:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-hemlibra-cambiera-il-mercato-dellemofilia/ 2018-10-04T11:10:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-italia-alessandro-casu-nuovo-direttore-stabilimento-di-scoppito/ 2018-10-04T12:23:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-roche-nuovo-ok-della-fda-rilancia-xolair/ 2018-10-04T12:44:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-la-sfida-di-bourla-si-chiama-ma/ 2018-10-04T13:15:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-bene-ultra-rapid-lispro-in-due-studi-di-fase-avanzata/ 2018-10-04T13:31:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-10-mln-di-dollari-per-piattaforma-a-biotech-di-hong-kong/ 2018-10-04T17:04:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bluebird-bio-ema-accetta-domanda-per-lentiglobin/ 2018-10-05T10:39:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-175-mln-di-dollari-per-candidato-contro-epatite-b/ 2018-10-05T10:49:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boston-pharmaceuticals-accordo-con-novartis-e-gsk-per-nuova-pipeline/ 2018-10-05T11:51:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/frazier-ceo-msd-rivedere-supply-chain-per-contenere-prezzi-farmaci/ 2018-10-05T12:29:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-usa-la-carica-delle-manager/ 2018-10-05T13:01:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-premiata-ai-superbrands-awards-2018/ 2018-10-05T14:50:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-lancia-nuovo-dispositivo-per-chirurgia-vertebrale/ 2018-10-08T10:46:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-europeo-sta-per-chiudersi-un-anno-doro/ 2018-10-08T11:08:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-chi-conosce-il-nuovo-mdr-europeo/ 2018-10-08T13:08:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-yescarta-prima-terapia-car-t-nel-regno-unito/ 2018-10-08T16:03:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/akcea-ok-fda-a-tegsedi/ 2018-10-08T16:40:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-arriva-in-italian-combo-a-base-di-darunavir/ 2018-10-08T16:01:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-ancora-dati-positivi-per-spinraza/ 2018-10-09T14:06:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/upsa-stada-in-pole-position/ 2018-10-09T17:45:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-a-publicis-la-strategia-offline-e-digital-per-1-miliardo-di-dollari/ 2018-10-09T14:56:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-ibm-intelligenza-artificiale-per-i-nefrologi-italiani/ 2018-10-09T16:30:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ema-e-fda-accolgono-domanda-siponimod/ 2018-10-09T15:41:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-arriva-in-italia-primo-vaccino-animal-health/ 2018-10-09T17:48:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-sempre-piu-evidenze-a-favore-di-cladribina-compresse/ 2018-10-10T09:53:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-con-bourla-gli-stessi-top-manager-di-read/ 2018-10-10T10:56:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-otezla-verso-nuove-indicazioni/ 2018-10-10T13:38:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-stelara-efficace-contro-la-colite-ulcerosa/ 2018-10-10T13:52:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-brexit-dei-trial-clinici-in-uk-solo-597-sperimentazioni-nel-2017/ 2018-10-10T14:17:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-fda-estende-gardasil-9-a-uomini-e-donne-fino-ai-45-anni/ 2018-10-10T14:42:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biopharma-in-usa-il-mercato-torna-a-crederci/ 2018-10-11T12:58:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-ok-aifa-a-tripla-combo-bpco/ 2018-10-11T14:04:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-apre-le-porte-alla-silicon-valley/ 2018-10-11T14:19:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/marketing-farmaceutico-non-solo-roi/ 2018-10-11T19:31:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rgenix-su-due-candidati-antitumorali/ 2018-10-11T15:45:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-passi-in-avanti-in-usa-per-il-biosimilare-renflexis/ 2018-10-11T18:41:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-italia-il-gruppo-cloudia-vince-la-seconda-edizione-del-rare-disease-hackathon/ 2018-10-11T17:00:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiomedica-primo-medical-device-challenge-per-sostenere-dynamo-camp/ 2018-10-14T15:40:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-arriva-in-italia-kisquali/ 2018-10-12T10:38:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-nuova-partnership-con-proteus-per-sviluppo-farmaci-digitali/ 2018-10-12T13:07:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-accordo-con-compungen-per-testare-combo-opdivo/ 2018-10-12T15:00:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-una-survey-e-un-docufilm-per-capire-meglio-la-sm/ 2018-10-12T15:24:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/open-innovation-perche-piace-tanto-alle-pharma/ 2018-10-12T15:48:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intersystem-e-fondazione-gemelli-accordo-per-ospedale-40/ 2018-10-15T10:39:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-kadcyla-raggiunge-endpoint-studio-fase-iii/ 2018-10-15T12:28:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covatec-scendono-le-stime-di-crescita/ 2018-10-15T13:47:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/unaltra-biotech-cinese-in-borsa-ipo-per-innovent-a-hong-kong/ 2018-10-15T14:02:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-nuovo-impianto-in-italia-per-la-produzione-di-fostemsavir/ 2018-10-15T14:20:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-animal-health-vince-il-lean-healthcare-e-lifescience-award-2018/ 2018-10-15T15:00:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sifi-partnership-con-polpharma-per-le-terapie-oftalmiche/ 2018-10-15T16:51:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-stop-agli-investimenti-in-uk-senza-accordo-post-brexit/ 2018-10-16T10:03:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dr-reddy-a-neopharma-la-produzione-dei-principi-attivi/ 2018-10-16T11:05:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-pfizer-arriva-in-italia-avelumab/ 2018-10-16T12:29:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-usa-negli-spot-anche-il-prezzo-del-farmaco/ 2018-10-16T12:57:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allogene-ancora-unipo-per-le-car-t/ 2018-10-16T13:43:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ionis-accordo-con-roche-per-sviluppo-candidato-contro-degenerazione-maculare/ 2018-10-16T14:41:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-in-california-uno-stabilimento-per-le-terapie-con-cellule-staiminali/ 2018-10-17T17:36:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-verso-lesternalizzazione-delle-attivita-di-ricerca/ 2018-10-17T10:51:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-msd-i-vincitori-del-patients-digital-health-awards/ 2020-11-10T08:24:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/samsung-bioepis-arriva-in-italia-biosimilare-di-adalimumab/ 2018-10-17T14:01:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-ottimo-q3/ 2018-10-17T16:02:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-europarlamentari-italiani-troppe-criticita-riconsiderare-milano/ 2018-10-17T17:03:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-shire-il-giappone-dice-si/ 2018-10-18T10:55:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-ministro-savona-amsterdam-in-ritardo-milano-puo-sperare/ 2018-10-18T10:54:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-acquisisce-endocyte/ 2018-10-18T13:28:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zuckerberg-piattaforma-open-source-per-focolai-malattie-virali/ 2018-10-18T14:32:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-nel-q3-bene-i-md-male-il-farmaceutico/ 2018-10-18T15:13:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/apple-e-zimmer-biomet-per-la-chirurgia-ortopedica/ 2018-10-18T15:20:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-genzyme-nasce-research-to-care-per-sostenere-la-ricerca-italiana/ 2018-10-19T10:16:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-pfizer-funzione-combo-keytruda-inlyta-nel-tumore-del-rene/ 2018-10-19T10:48:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-nuove-linee-guida-fda-contro-attacchi-informatici/ 2018-10-19T11:05:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-accordo-rd-con-morphic-per-le-malattie-fibrotiche/ 2018-10-19T13:35:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-resisiste-allassalto-dei-biosimilari/ 2018-10-19T14:46:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-pronti-i-report-regionali-sui-consumi-dei-farmaci/ 2018-10-19T15:01:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/seqirus-ok-del-chmp-a-vaccino-influenzale-quadrivalente-cellulare/ 2018-10-21T17:55:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ok-da-fda-per-dupixent-nellasma/ 2018-10-22T11:22:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-bene-alpelisib-nel-tumore-al-seno/ 2018-10-22T12:44:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-ok-fda-a-rivaroxaban-e-asa-per-riduzione-eventi-cardiovascolari/ 2018-10-22T12:50:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ottima-performance-di-lynparza-nel-tumore-ovarico/ 2018-10-22T13:59:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-nuovo-cfo-nel-2019/ 2018-10-22T14:35:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/umanizzare-i-dati-del-marketing-ci-prova-fcb-health/ 2018-10-22T15:59:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fb-health-diventa-neuraxpharm-italy/ 2018-10-23T11:25:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-a-rischio-anche-lingresso-dei-ricercatori-in-uk/ 2018-10-23T14:12:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-quote-in-innate-pharma-per-pipeline-antitumorale/ 2018-10-23T14:26:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-accordo-con-enterome-per-candidato-malattia-di-crohn/ 2018-10-23T14:38:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-loxo-oncology-nuove-evidenze-per-larotrectinib/ 2018-10-23T15:42:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-i-risultati-positivi-di-entrectinib-allesmo-di-monaco/ 2018-10-23T15:21:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/siemens-accordo-con-start-up-israeliana-per-selfie-medico/ 2018-10-24T10:37:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-sale-lutile-netto-nel-q3/ 2018-10-24T10:49:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-nuovo-centro-di-distribuzione-a-darmstadt/ 2018-10-24T11:03:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-molto-bene-upadacitinib/ 2018-10-24T13:07:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-tumore-al-seno-funziona-la-combo-tecentriq-chemioterapia-nel-triplo-negativo/ 2018-10-24T13:31:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-arriva-in-italia-guselkumab/ 2018-10-24T15:42:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-shionogi-ok-di-fda-allantinfluenzale-xofluza/ 2018-10-25T10:54:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-orion-obiettivo-raggiunto-per-darolutamide/ 2018-10-25T12:38:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-lancia-pills-of-art-larte-in-un-click/ 2018-10-25T12:50:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-e-flex-digital-health-continua-la-partnership-per-md-diabete/ 2018-10-25T13:00:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-italia-alessandro-galassini-nuovo-direttore-dello-stabilimento-di-anagni/ 2018-10-25T13:13:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-parlamento-vota-amsterdam-il-no-di-lancini/ 2018-10-25T16:27:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-nel-q3-utili-superiori-alle-stime/ 2018-10-26T12:50:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boston-scientific-grande-performance-nel-q3/ 2018-10-26T12:54:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dompe-restyling-per-gli-usa/ 2018-10-26T13:24:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-eisai-bene-il-candidato-contro-lalzheimer-ma-gli-analisti-sono-freddi/ 2018-10-26T14:46:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-q3-trascinato-da-otezla/ 2018-10-26T14:59:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-i-dati-dello-studio-traverse-sui-vaccini-contro-hiv/ 2018-10-26T15:08:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-carlo-colombini-entra-nel-cda/ 2018-10-29T11:18:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-nuovo-sito-mondiale-per-i-vaccini-in-olanda/ 2018-10-29T17:46:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-accordo-con-hub-britannico-per-scoprire-farmaci-con-le-onde-sonore/ 2018-10-29T12:06:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-e-pfizer-sinergia-per-la-nash/ 2018-10-29T13:24:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-stime-in-rialzo-con-la-performance-degli-antihiv-nel-q3/ 2018-10-29T15:02:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-insediate-le-commissioni/ 2018-10-29T17:43:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-italia-vivek-devaraj-e-il-nuovo-country-head/ 2018-10-30T11:49:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-a-grunenthal-i-diritti-di-nexium/ 2018-10-30T12:34:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-lancia-soluzione-integrata-per-ecografia-mammaria/ 2018-10-30T12:58:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-gardasil-sempre-piu-golden-bullet/ 2018-10-30T13:28:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/per-karo-pharma-654-mln-cash-da-fondo-eqt/ 2018-10-30T15:16:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-scommette-sul-silenziamento-genico/ 2018-10-30T15:06:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assogenerici-cambio-al-vertice-dellibg-stefano-collatina-nuovo-coordinatore/ 2018-10-31T15:51:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-bene-le-vendite-nel-q3-repatha-segna-il-passo/ 2018-10-31T16:04:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-nasce-jpod-hub-di-networking/ 2018-10-31T13:15:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-il-q3-conferma-il-trend-di-crescita/ 2018-10-31T16:31:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-volano-entyvio-e-ninlaro/ 2018-10-31T14:47:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-q3-inferiore-alle-aspettative/ 2018-10-31T15:48:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-dietro-front-su-richiesta-approvazione-biosimilare-di-rituximab-negli-usa/ 2018-11-05T18:14:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ok-della-fda-americana-a-lorbrena-tumore-del-polmone/ 2018-11-05T18:35:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-valutazione-accelerata-di-ema-per-immissione-in-commercio-quizartinib-lma/ 2018-11-05T18:13:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-rivede-al-ribasso-previsioni-sulle-vendite-di-humira/ 2018-11-05T14:58:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-una-triplice-vocazione/ 2018-11-05T17:13:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-buyback-da-15-mld-di-corone/ 2018-11-05T17:59:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-sciences-sempre-piu-management-in-rosa/ 2018-11-06T14:07:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-roche-funziona-combo-revlimid-rituxan-nel-linfoma-follicolare/ 2018-11-09T12:06:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-trulicity-riduce-il-rischio-di-infarto/ 2018-11-06T14:17:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-a-covis-pharma-i-diritti-di-tre-farmaci-per-asma-e-rinite/ 2018-11-06T18:43:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-grossa-flessione-nel-q3/ 2018-11-06T17:00:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-dallesperienza-hiv-unidea-per-il-vaccino-universale/ 2018-11-06T17:11:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-un-futuro-sempre-piu-targato-dupixent/ 2018-11-07T11:18:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-le-vendite-di-eleya-in-usa-superano-il-miliardo-di-dollari/ 2018-11-07T12:14:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-autunno-doro-per-gli-antitumorali/ 2018-11-07T13:04:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-piccoli-merger-mirati-per-il-futuro/ 2018-11-07T16:37:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/yuhan-a-janssen-lo-sviluppo-di-lazertinib/ 2018-11-07T15:00:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-nuovi-dati-positivi-per-la-terapia-combinata-monocompressa/ 2018-11-07T15:51:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-quali-strategie-per-i-prossimi-anni/ 2018-11-08T13:42:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-aumentano-le-vendite-dei-nuovi-farmaci/ 2018-11-08T13:40:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-mai-cosi-in-alto-da-dieci-anni/ 2018-11-08T15:07:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intec-pharma-al-via-fase-3-per-candidato-parkinson/ 2018-11-08T15:44:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-abbvie-ok-fda-a-combo-con-pomalyst-celgene-nel-mieloma-multiplo/ 2018-11-08T16:45:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-crescono-le-vendite/ 2018-11-08T16:57:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/endo-nel-2020-il-lancio-del-farmaco-contro-la-cellulite/ 2018-11-09T17:46:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-nuovi-positivi-dati-per-fremanezumab/ 2018-11-09T13:35:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/upsa-angelini-nella-short-list-per-lacquisto/ 2018-11-09T14:34:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-lancia-gateway-of-pacific/ 2018-11-09T15:34:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-paziente-sempre-piu-informato-anche-dalle-pharma/ 2018-11-09T16:24:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-li-bassi-migliorare-laccesso-ai-farmaci-e-rafforzare-sinergia-con-regioni/ 2018-11-09T17:26:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/i-quaderni-di-health-industry/ 2020-11-10T10:52:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/18914/ 2020-11-10T11:54:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/18917/ 2020-11-10T11:47:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/social-media-e-marketing-farmaceutico/ 2020-11-10T11:54:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/le-4-nuove-p-del-marketing-farmaceutico/ 2020-11-10T11:53:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-lutathera-superstar-del-q3/ 2018-11-12T14:46:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-e-theravance-ok-della-fda-a-yupelri/ 2018-11-12T14:45:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-closing-operazione-shire-entro-l8-gennaio/ 2018-11-12T20:41:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-david-feinberg-a-capo-delle-attivita-healthcare/ 2018-11-12T17:10:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-funziona-candidato-per-colangite-sclerosante-primaria/ 2018-11-12T17:19:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/md-cina-un-mercato-che-vale-quasi-6-miliardi-di-dollari/ 2018-11-12T17:30:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-a-sobi-i-diritti-di-synagis-per-15-mld-di-dollari/ 2018-11-13T14:03:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antitumorali-nel-2024-ancora-in-testa-roche-celgene-e-bms/ 2018-11-13T14:17:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-fast-review-fda-per-tecentriq/ 2018-11-13T15:03:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-nel-q3-bene-xarelto-male-lanimal-health/ 2018-11-13T15:24:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cuore-a-brescia-intervento-unico-al-mondo-di-sostituzione-di-un-micropacemaker-in-una-giovane/ 2019-05-31T14:26:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-ipo-da-500-mln-di-dollari-la-piu-alta-del-biotech/ 2018-11-13T15:57:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomarin-un-musical-sullemofilia-a-new-york/ 2018-11-13T17:11:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-ibm-e-aimac-nasce-filos-chatbox-per-malati-oncologici/ 2018-11-14T11:04:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zambon-alla-conquista-della-cina-con-fluimucil/ 2018-11-14T14:27:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-licenza-royalty-free-per-mavyret-nei-paesi-a-basso-reddito/ 2018-11-14T11:24:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-acquisisce-lapp-streams-da-deepmind/ 2018-11-14T11:29:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nestle-punta-sullimmunoterapia-desensibilizzante/ 2018-11-14T14:22:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-abbassa-le-stime/ 2018-11-14T15:17:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nessuna-intenzione-di-cedere-sandoz/ 2018-11-15T11:39:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-keytruda-raggiunge-obiettivo-anche-nel-tumore-dellesofago/ 2018-11-15T11:41:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epis-2018-appuntamento-europeo-della-patient-advocacy-co-creato-da-novartis/ 2020-11-10T08:24:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-la-ce-approva-cabozantinib/ 2018-11-15T14:55:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-alla-fda-la-richiesta-per-lasmiditan/ 2018-11-15T14:59:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alcon-verso-lo-spinoff/ 2018-11-15T15:12:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-e-mission-therapeutics-insieme-contro-alzheimer-e-parkinson/ 2018-11-16T11:53:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-per-fine-anno-richiesta-fda-per-emgality-nella-cefalea-a-grappolo/ 2018-11-16T14:26:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-accordo-con-epizyme-per-oncologia-di-precisione/ 2018-11-16T14:37:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-rolling-submission-alla-fda-per-vaccino-contro-ebola/ 2018-11-16T14:52:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-servizio-sanitario-britannico-a-rischio-personale/ 2018-11-16T15:47:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-italia-la-jc-band-contro-la-violenza-sulle-donne/ 2018-11-16T16:00:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tesaro-sul-mercato/ 2018-11-19T15:29:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-parere-positivo-del-chmp-per-apalutamide/ 2018-11-19T11:52:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-negli-usa-da-gennaio-aumenti-per-41-prodotti/ 2018-11-19T18:16:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-fda-a-promacta-nellanemia-aplastica-grave/ 2018-11-19T15:08:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-cessione-farmaci-off-patent-in-cina/ 2018-11-19T15:29:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medicinali-chinolonici-ema-sospende-autorizzazione-a-immissione-in-commercio/ 2018-11-19T16:08:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-charlotte-di-sex-and-the-city-testimonial-campagna-web-coolsculpting/ 2018-11-20T17:41:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/seqirus-amplia-la-produzione-di-flucelvax-tetra/ 2018-11-20T14:42:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genentech-partnership-con-immunocore-per-anticorpo-bispecifico-contro-il-cancro/ 2018-11-20T14:56:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-sta-preparando-il-dopo-soriot/ 2018-11-20T15:27:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amazon-pigliatutto-negli-otc-meglio-allearsi/ 2018-11-20T17:02:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-con-i-fuori-sede-a-teatro-si-parla-di-cancro/ 2018-11-20T17:26:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-syntropy-jv-tra-merck-kgaa-e-biotech-palantir/ 2018-11-21T15:20:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-stime-in-rialzo/ 2018-11-21T15:30:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boston-scientific-torna-a-comprare-presa-la-britannica-btg/ 2018-11-21T15:41:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-lancia-app-per-parkinson-basata-su-intelligenza-artificiale/ 2018-11-21T16:02:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leo-pharma-partnership-con-pellepharm-per-malattie-rare-della-pelle/ 2018-11-21T16:16:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nuove-positive-evidenze-per-praluent-dallo-studio-odyssey/ 2018-11-21T16:37:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-corte-ue-arriva-il-via-libera-allutilizzo-oftalmico-off-label-di-avastin-a-carico-del-ssn-a-determinate-condizioni/ 2018-11-21T17:54:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-formazione-del-british-medical-journal-arriva-in-italia/ 2018-11-23T08:16:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lorefice-presidente-della-commissione-affari-sociali-a-beneficiare-di-questi-percorsi-formativi-saranno-i-cittadini-un-progetto-ambizioso/ 2018-11-22T11:53:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ripa-di-meana-fiaso-bmj-ha-da-tempo-saputo-mettere-a-frutto-ai-fini-formativi-la-sua-esperienza-di-prestigiosa-rivista-medica/ 2018-11-22T12:03:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vimercati-fism-disponibili-a-collaborare-con-il-progetto-di-sics-per-la-creazione-di-board-di-esperti-in-ambito-specialistico/ 2018-11-22T11:58:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lenzi-iniziative-come-queste-sono-strumenti-indispensabili-per-i-nostri-operatori-sanitari/ 2018-11-22T12:06:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boggetti-assobiomedica-le-nostre-imprese-credono-profondamente-nellimportanza-dellaggiornamento-continuo-in-medicina/ 2018-11-22T12:09:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/creazzola-sifo-sosteniamo-formazione-realmente-continua-e-qualificata-rivolta-al-farmacista-con-un-approccio-formativo-multidisciplinare/ 2018-11-22T15:05:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hausermann-assogenerici-contribuira-ad-una-reale-e-condivisa-cultura-della-comunicazione-scientifica-nel-nostro-paese/ 2018-11-22T15:05:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ok-fda-a-daurismo/ 2018-11-23T11:49:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-abbvie-nuova-approvazione-per-venetoclax/ 2018-11-23T14:14:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-shire-ce-il-si-anche-della-commissione-europea/ 2018-11-23T14:24:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genentech-scommette-sullinibizione-jak-1-nellasma/ 2018-11-23T14:39:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-lascia-il-ceo-della-mhra/ 2018-11-23T16:02:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-italia-200-milioni-per-nuovi-investimenti-e-100-assunzioni-under-30/ 2018-11-23T16:25:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-precisazione-sui-biosimilari/ 2018-11-26T11:26:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-un-hub-in-israele-per-lavorare-sulle-car-t/ 2018-11-26T11:40:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-dopo-lok-ue-lxturna-allesame-prezzo-in-europa/ 2018-11-26T17:20:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogne-guarda-in-cina-per-la-neurologia/ 2018-11-26T16:25:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-sul-tavolo-il-futuro-di-consuemr-e-animal-health/ 2018-11-26T16:27:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eisai-lancia-furthermore-campagna-sul-carcinoma-mammario-metastatico/ 2018-11-26T17:23:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/loxo-oncology-bayer-ok-fda-a-vitrakvi/ 2018-11-27T14:28:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alcon-novartis-i-dettagli-dello-spin-off/ 2018-11-27T14:48:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-big-data-tag-e-prove-real-world-per-sorveglianza-post-marketing-dei-md/ 2018-11-27T15:29:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-siena-un-hub-per-la-ricerca-biomedica/ 2018-11-27T16:37:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-roche-e-abbvie-protagoniste-nella-lma/ 2018-11-27T17:30:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sun-pharma-si-espande-in-giappone-con-la-dermatologia/ 2018-11-27T17:35:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-ok-da-ema-a-delstrigo-e-pifeltro/ 2018-11-28T12:10:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lifescience-un-premio-alleccellenza-e-allinnovazione/ 2018-11-28T15:18:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-su-jecure-therapeutics-acquisto-in-chiave-nash/ 2018-11-28T14:05:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alcon-il-trattamento-della-miopia-core-business-dei-prossimi-anni/ 2018-11-28T14:38:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-bene-la-triplice-combo-per-la-fibrosi-cistica/ 2018-11-28T16:13:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-lancia-negli-usa-il-generico-di-epipen/ 2018-11-28T16:51:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celltrion-ok-fda-a-truxima-biosimilare-di-mabthera/ 2018-11-29T12:03:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-via-libera-a-xospata-lma/ 2018-11-29T15:09:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-aumenta-lipo-la-biotech-vale-quasi-8-mld-di-dollari/ 2018-11-29T15:42:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-consumer-healthcare-unilever-vicina-allacquisto/ 2018-11-29T15:41:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-lancia-ventana-pan-trk-nuovo-test-in-vitro-per-tumori/ 2018-11-29T16:19:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-la-ce-approva-gilenya-negli-adolescenti-con-sm/ 2018-11-29T17:21:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nuova-sede-nellhub-delle-life-sciences-di-lonfra/ 2018-11-30T15:17:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/congresso-sifo-li-bassi-presto-documento-governance-farmaceutica/ 2018-11-30T15:33:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-su-nutrino-health-per-allargare-il-business-diabete/ 2018-11-30T18:16:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-pronta-la-cura-dimagrante-post-monsanto/ 2018-11-30T16:46:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ancora-sei-mesi-con-lyrica/ 2018-11-30T17:10:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-sei-idee-di-acro-per-trasformare-uk-in-un-paese-che-attrae-ricerca/ 2018-11-30T17:28:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-lancia-due-programmi-dalla-piattaforma-viewics/ 2018-12-03T11:09:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-otsuka-efficace-combo-rexulti-zoloft-nel-ptsd/ 2018-12-03T15:51:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-ottimi-risultati-per-il-follow-up-di-yescarta/ 2018-12-03T17:27:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merdian-bioscience-ok-fda-a-test-cmv-per-neonati/ 2018-12-03T15:49:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-la-strategia-di-difesa-di-humira-negli-usa/ 2018-12-03T14:41:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-nuove-evidenze-per-ninlaro-nel-mieloma-multiplo/ 2018-12-03T15:19:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-toscana-life-sciences-regions4permed-per-la-medicina-di-precisione/ 2018-12-04T12:24:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-bene-candidato-anticorpo-bispecifico-nel-mm/ 2018-12-04T15:06:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-tesaro-e-fatta/ 2018-12-04T17:58:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-unilever-il-brand-horlicks-di-gsk/ 2018-12-04T15:53:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/icr-in-europa-tempi-troppo-lenti-per-i-farmaci-oncologici-innovativi/ 2018-12-04T18:03:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-obiettivo-raggiunto-per-luspatercept/ 2018-12-04T16:42:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/processo-menarini-assolti-i-fratelli-aleotti/ 2018-12-05T14:33:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-shire-via-libera-dagli-azionisti/ 2018-12-05T14:31:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-linee-guida-per-lo-sviluppo-dei-farmaci-contro-la-nash/ 2018-12-05T14:29:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-bene-darzalex-prima-linea-contro-mieloma-multiplo/ 2018-12-05T15:16:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-accordo-con-domain-per-sviluppo-farmaci-snc/ 2018-12-05T15:58:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lean-management-nasce-in-italia-la-salute-organizzativa/ 2018-12-05T16:36:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharmanutra-entra-in-farmindustria/ 2018-12-05T17:24:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-un-mld-di-dollari-per-un-hub-in-uk-nonostante-la-brexit/ 2018-12-06T18:23:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-chi-vendera-di-piu-nel-2024/ 2018-12-06T14:31:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-svolta-digitale-nella-ricerca-sullasma/ 2018-12-06T15:01:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-e-icagen-partnership-in-neurologia/ 2018-12-06T16:02:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-parnership-governo-uk-msd-e-janssen/ 2018-12-06T16:42:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-il-ceo-baumann-entro-2022-ebitda-a-16-miliardi-di-euro/ 2018-12-06T16:41:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-e-il-giorno-del-nasdaq/ 2018-12-07T14:30:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-fda-a-tecentriq-chemio-prima-linea-nel-tumore-al-polmone/ 2018-12-07T15:00:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-nel-2019-il-generico-di-epipen-negli-usa/ 2018-12-07T15:17:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fresenius-espansione-cinese/ 2018-12-07T15:37:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-la-rivoluzione-del-mercato-unbranded/ 2018-12-07T16:00:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/milano-ci-prova-ancora-dopo-ema-si-candida-a-ospitare-il-tub/ 2018-12-07T17:20:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-la-rivoluzione-millennial/ 2018-12-10T11:44:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-il-nuovo-ceo-e-daniel-oday/ 2018-12-10T18:29:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-piattaforma-ia-per-valutare-small-molecule/ 2018-12-10T13:59:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/apple-arriva-sul-mercato-il-nuovo-orologio-con-lecg/ 2018-12-10T14:35:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-medtech-cinese-vola-in-borsa-10-mld-di-dollari-per-wuxi-apptec/ 2018-12-10T15:21:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-come-cambia-la-governance-in-italia/ 2018-12-10T18:15:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eisai-e-ucl-pronto-candidato-contro-alzheimer/ 2018-12-11T11:16:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-partnership-con-e-therapeutics-al-centro-ricerche-di-londra/ 2018-12-11T11:28:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiotech-federchimica-palmisano-indicazioni-positive-nella-nuova-governance-farmaceutica/ 2018-12-11T18:43:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-dopo-israele-un-impianto-di-produzione-anche-in-cina/ 2018-12-11T15:21:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zambon-da-fda-qidp-e-fast-track-per-colistimetato-sodico/ 2018-12-11T17:33:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-la-borsa-di-hong-kong-attrae-le-start-up/ 2018-12-11T17:51:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-arriva-in-italia-emicizumab-per-lemofilia-a/ 2018-12-12T11:50:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-accordo-con-entera-per-biologici-orali/ 2018-12-12T16:20:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-piu-di-400-mila-persone-hanno-ricevuto-il-vaccino-contro-ebola/ 2018-12-12T16:35:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/luma-per-la-psoriasi-a-placche-dispositivo-che-funziona-con-smartphone/ 2018-12-12T16:46:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-loxo-oncology-ok-fda-a-larotrectinib/ 2018-12-12T17:02:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-ancora-scarse-le-scorte-di-shingrix-nel-2019/ 2018-12-12T17:22:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-partnership-con-ac-immune-per-candidatop-biotech-contro-alzheimer/ 2018-12-13T15:07:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/xenotherapeutics-parte-sperimentazione-umana-per-pelle-temporanea-dopo-ustioni/ 2018-12-13T15:21:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-msd-alleanza-allinsegna-di-keytruda/ 2018-12-13T15:38:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-screening-con-ia-per-retinopatia-diabetica/ 2018-12-13T16:03:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-turnover-nellorganizzazione-commerciale/ 2018-12-13T16:16:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-biosimilari-efficaci-e-intercambiabili-con-gli-originator/ 2018-12-13T17:01:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-55-approvazioni-nel-2018-e-record/ 2018-12-14T12:29:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/akero-a-breve-sperimentazione-candidato-nash-in-licenza-da-amgen/ 2018-12-14T13:28:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-studio-usa-15-aree-a-rischio-sovraffollamento-terapeutico/ 2018-12-14T13:58:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-e-biocon-in-attesa-della-fda-per-il-generico-di-lantus/ 2018-12-14T14:22:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-per-il-2019-bilancio-inferiore-per-la-brexit/ 2018-12-14T18:02:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-riesplode-il-caso-baby-powder/ 2018-12-16T16:08:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-nella-corsa-a-upsa-sinserisce-la-giapponese-taisho/ 2018-12-17T13:50:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ok-chmp-per-zirabev-biosimilare-di-avastin/ 2018-12-17T16:54:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-healthcare-ecco-edison-piattaforma-digitale-per-ia-in-sanita/ 2018-12-17T15:28:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-dal-2020-nuova-sede-a-tel-aviv/ 2018-12-17T15:42:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-vicina-ad-antelliq-per-completare-lofferta-animal-health/ 2018-12-17T16:21:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-accordo-con-evidation-per-sviluppo-biomarker-digitali/ 2018-12-17T16:41:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bellicum-primi-dati-positivi-per-nuova-terapia-car-t/ 2018-12-18T17:29:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baby-powder-johnson-si-difende/ 2018-12-18T15:00:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-nuovo-team-esecutivo/ 2018-12-18T17:57:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-fibrogen-per-roxadustat-la-prima-approvazione-e-in-ucina/ 2018-12-18T16:30:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vas-narasimhan-idea-reinsurance-per-le-terapie-piu-costose/ 2018-12-18T16:51:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aspen-pharmacare-giu-in-borsa/ 2018-12-18T17:19:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/iss-ricciardi-si-dimette-lascio-un-istituto-solido-e-riorganizzato/ 2018-12-19T12:32:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-r-e-d-costa-sempre-piu-e-rende-sempre-meno/ 2018-12-19T15:06:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-e-pfizer-jv-per-una-nuova-realta-consumer-health/ 2018-12-19T15:09:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-partnership-con-spin-off-di-eisai-per-terapie-immunitarie-contro-il-cancro/ 2018-12-19T15:31:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-lavori-in-corso-per-kymriah/ 2018-12-19T15:50:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/md-la-fda-completa-le-linee-guida/ 2018-12-19T16:24:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-lynparza-e-roxadustat-centrano-obiettivi-studi/ 2018-12-20T11:29:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-ritira-protesi-seno-dal-mercato-europeo/ 2018-12-20T12:04:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/upsa-e-uffciale-lofferta-di-taisho/ 2018-12-20T14:24:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-migliorano-le-stime-per-il-2019/ 2018-12-20T14:21:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-accordo-con-la-cinese-gan-lee-per-produrre-biosimilari-insulina/ 2018-12-20T14:32:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adv-negli-usa-per-i-farmaci-oncologici-si-spendono-500-mln-di-dollari/ 2018-12-20T17:13:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-cambio-ai-vertici-della-bu-oncology/ 2018-12-21T14:39:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/m-a-che-2019-fara/ 2018-12-21T14:55:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-accordo-con-agenus-per-sviluppo-farmaci-immunoncologici/ 2018-12-21T15:11:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2018-la-grande-fuga-dalla-consumer-health/ 2018-12-21T15:38:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scaccabarozzi-farmindustria-della-nuova-governance-farmaceutica-non-salviamo-nulla/ 2018-12-21T15:57:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-usa-a-gennnaio-nuovi-aumenti-dei-prezzi/ 2018-12-21T17:18:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-msd-leader-dellindice-dow-jones-2018/ 2019-01-03T10:04:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-investe-in-cina-120-mln-di-dollari-per-biotech-antengene/ 2019-01-03T10:28:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-msd-per-vaxelis-via-libera-anche-dalla-fda/ 2019-01-03T11:15:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-ok-fda-a-ultomiris/ 2019-01-03T12:57:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/manovra-ecco-le-tappe-per-la-sanita/ 2019-01-03T14:18:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-canadese-lancia-due-test-biopsie-liquide/ 2019-01-03T15:48:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/urogen-pharma-lex-novartis-liz-barrett-nuovo-ceo/ 2019-01-04T09:44:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/veracyte-e-johnson-test-genomici-per-lo-screening-del-tumore-al-polmone/ 2019-01-04T10:14:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-bms-lanno-inizia-con-il-big-takeover/ 2019-01-04T14:53:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-rischio-riduzione-attivita-per-lo-shutdown/ 2019-01-04T15:20:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-negli-usa-e-gia-record/ 2019-01-07T09:53:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-accordo-con-click-therapeutics-su-app-per-depressione-maggiore/ 2019-01-07T12:02:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-ibm-ecco-iqcast-la-sentinella-dellipoglicemia-basata-sullia/ 2019-01-07T11:54:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-bms-penale-da-22-mld-di-dollari-per-chi-si-sfila-dalla-fusione/ 2019-01-07T12:27:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-regeneron-nuovo-accordo-per-limmuno-oncologia/ 2019-01-07T14:09:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celltrion-sbarca-in-cina/ 2019-01-07T16:37:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-celgene-una-centrale-di-energia-scientifica/ 2019-01-08T11:51:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-accordo-con-la-sudcoreana-yuhan-in-chiave-nash/ 2019-01-08T13:22:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-acquisisce-loxo-oncology-e-lanno-dei-merger-nelloncologia/ 2019-01-08T14:59:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-controcorrente-nessuna-cessione-della-bu-otc/ 2019-01-08T15:30:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-jose-baselga-a-capo-della-r-d-in-oncologia/ 2019-01-08T15:54:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-europe-accordo-con-esperion-per-acido-bempedoico-ezetimibe-in-europa/ 2019-01-09T12:19:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/12157/ 2019-01-09T13:50:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ufficio-ad-hoc-per-velocizzare-sviluppo-dei-farmaci/ 2019-01-09T16:57:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cellectis-il-futuro-delle-car-t-e-nellapproccio-allogenico/ 2019-01-09T17:12:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/marketing-pharma-in-usa-non-conosce-crisi/ 2019-01-09T17:33:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-futuro-in-crescita-nel-campo-della-psoriasi/ 2019-01-10T14:57:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-gruppo-ricerca-e-sviluppo-a-kendall-square/ 2019-01-10T16:05:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/verily-dopo-novartis-nuove-partnership/ 2019-01-10T17:13:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tmunity-therapeutics-appuntamento-allasco-per-le-nuove-car-t/ 2019-01-10T17:06:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-nessuna-crisi-per-eylea/ 2019-01-11T11:52:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-2019-anno-di-trasformazione/ 2019-01-11T14:10:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/walmsley-gsk-con-tesaro-raddoppiata-pipeline-immuno-oncologica/ 2019-01-11T16:48:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-cindy-perettie-nuovo-ceo-di-foundation-medicine/ 2020-11-10T09:01:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-cambia-la-struttura-organizzativa/ 2019-01-11T16:50:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ma-2019-bms-celgene-e-stato-solo-un-aperitivo/ 2019-01-11T17:08:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vas-narasimhan-novartis-tra-innovazione-e-le-sfide-dei-costi/ 2019-01-11T16:53:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/acquisizioni-scendono-in-campo-pfizer-e-biogen/ 2019-01-14T11:47:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/seqirus-via-libera-ce-a-flucelvax-tetra/ 2019-01-14T12:11:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ottimi-risultati-per-caplacizumab-nello-studio-hercules/ 2019-01-14T14:34:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-procede-bene-il-piano-di-riassesto/ 2019-01-14T16:37:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-barra-dritta-sulloncologia/ 2019-01-14T17:32:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-amgen-comincia-in-giappone-lavventura-di-romosozumab/ 2019-01-14T16:56:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-e-botox-il-competitor-dei-cgrp-nellemicrania/ 2019-01-15T11:23:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-successo-di-keytruda-in-monoterapia-contro-il-cancro-esofageo/ 2019-01-15T11:52:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-ok-ce-a-opdivo-yervoy-come-trattamento-prima-linea-nel-rcc/ 2019-01-15T13:34:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-nel-marketing-si-punta-sempre-di-piu-ai-consumatori/ 2019-01-15T15:11:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/clovis-oncology-e-lei-la-protagonista-del-prossimo-deal/ 2019-01-15T16:51:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-misura-la-soddisfazione-di-cittadini-e-utenti/ 2019-01-15T17:07:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-con-hard-brexit-irlanda-a-rischio/ 2019-01-16T11:32:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-riviste-le-linee-guida-per-combattere-le-infezioni-batteriche/ 2019-01-16T15:54:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/manager-il-fascino-delle-biotech-specializzate-in-immuno-oncologia/ 2019-01-16T13:51:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-in-arrivo-unondata-di-terapie-cellulari-e-geniche/ 2019-01-16T14:17:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-tra-merger-e-ipo-sara-un-grande-2019/ 2019-01-16T15:05:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-teva-accordo-di-desistenza-su-generico-sensipar/ 2019-01-16T15:24:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/microsoft-mette-un-piede-nellhealthcare-system-usa/ 2019-01-17T12:04:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-per-keytruda-pubblicita-tv-real-world/ 2019-01-17T12:40:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-lancia-software-per-la-patologia-clinica-digitale/ 2019-01-17T14:04:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-raccomandazione-fda-per-evenity/ 2019-01-17T14:25:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-se-non-finisce-shutdown-rischio-blocco-approvazioni/ 2019-01-17T14:44:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-amgen-per-gli-scenziati-di-domani/ 2019-01-17T15:06:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-italiano-un-mld-di-investimenti-in-ricerca-e-sviluppo/ 2019-01-18T13:57:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-e-lo-strano-caso-di-restasis/ 2019-01-18T14:18:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-e-apple-studiano-insieme-apple-watch/ 2019-01-18T14:37:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-lexicon-per-sotagliflozin-la-fda-decide-a-marzo/ 2019-01-18T16:42:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fuga-verso-le-start-up-vp-gilead-sceglie-la-cina/ 2019-01-18T15:10:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-spesa-2017-in-crescita-a-quota-6-mld/ 2019-01-18T16:40:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-rita-cataldo-confermata-general-manager/ 2019-01-21T11:11:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-due-accordi-nellimmuno-oncologia/ 2019-01-21T11:41:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-con-big-data-institute-di-oxford-per-studiare-i-prossimi-farmaci/ 2019-01-21T12:10:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-lascia-il-presidente-philip-hampton/ 2019-01-21T15:48:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/samsung-bioepis-ok-fda-a-ontruzant-biosimilare-di-herceptin/ 2019-01-21T14:24:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-ce-approva-estensione-orkambi-a-pazienti-da-2-a-5-anni-di-eta/ 2019-01-21T15:05:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sla-avviso-alle-biotech-scoperto-possibile-obiettivo-terapeutico/ 2019-01-22T13:54:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/proteus-lancia-la-chemioterapia-digitale/ 2019-01-22T14:08:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-lascia-gli-emerging-market/ 2019-01-22T14:31:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pierre-fabre-la-combo-braftovi-mektovi-per-il-melanoma-piace-al-nice/ 2019-01-22T17:41:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/climate-change-anche-johnson-johnson-tra-le-aziende-piu-virtuose/ 2019-01-22T15:10:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-efpia-no-deal-disastroso-ecco-come-proteggere-i-pazienti/ 2019-01-22T17:25:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunochina-la-via-cinese-delle-car-t/ 2019-01-23T11:47:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-niente-big-deal-meglio-le-partnership/ 2019-01-23T11:46:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-fasi-finali-per-lhack/ 2019-01-23T12:08:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-pronta-nuova-il-2-progettata-al-computer/ 2019-01-23T15:15:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/auris-health-nel-mirino-di-jj/ 2019-01-23T15:38:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-si-prepara-a-un-2019-deludente/ 2019-01-23T17:10:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunoterapia-ancora-testa-a-testa-tra-keytruda-e-opdivo/ 2019-01-24T13:55:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biofarmaceutica-futuro-cinese-parola-di-stefan-oschmann/ 2019-01-24T14:13:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/auris-health-ecco-perche-piace-tanto-a-johnson/ 2019-01-24T14:36:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-lacqusizione-di-tesaro-ora-piace-anche-agli-investitori/ 2019-01-24T15:34:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bridgebio-pharma-300-mln-di-dollari-per-le-malattie-genetiche/ 2019-01-24T16:45:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-arriva-in-italia-minimed-670g/ 2019-01-24T16:43:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-italia-e-un-great-place-to-work/ 2019-01-25T12:00:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amazon-nel-2018-budget-record-per-lobbyng-oltre-14-mln-di-dollari/ 2019-01-25T14:01:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zambon-usa-e-cina-mercati-chiave/ 2019-01-25T14:25:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/12338/ 2019-01-25T15:32:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-biosciences-italia-scomparee-lad-giancarlo-parisi/ 2019-01-25T15:43:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genentech-alexander-hardy-nuovo-ceo/ 2020-11-10T08:56:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-da-merck-kgaa-due-candidati-per-editing-genoma/ 2019-01-28T10:13:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-sei-lanci-di-prodotti-e-due-assi-nella-manica/ 2019-01-28T10:31:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-humira-perde-in-europa/ 2019-01-28T10:51:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-governo-uk-100-mln-di-sterline-in-ai-per-evitare-lisolamento/ 2019-01-28T11:24:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-start-up-usa-studia-resistenza-agli-antibiotici-con-sequenziamento-genomico/ 2019-01-28T11:31:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-di-automedicazione-in-italia-2018-positivo/ 2019-01-28T17:33:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-del-nice-a-combo-venetoclax-rituximab/ 2019-01-29T11:48:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-novartis-a-governo-gb-piano-per-garantire-forniture/ 2019-01-29T14:19:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-vento-in-poppa-crescono-vendite-e-utili/ 2019-01-29T14:45:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/thermo-fischer-cede-pathology-unit-per-un-mld-di-dollari/ 2019-01-29T15:03:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-accordo-con-tencent-per-digital-health-in-cina/ 2019-01-29T17:00:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leo-pharma-punta-sulla-medicina-traslazionale/ 2019-01-29T17:49:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-2019-allinsegna-dei-farmaci-hi-tech/ 2019-01-30T11:20:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-bene-il-q4-ma-per-il-2019-abbassa-le-stime/ 2019-01-30T14:22:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-un-q4-2018-oltre-le-previsioni/ 2019-01-30T15:19:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-2019-al-di-sotto-delle-stime/ 2019-01-30T15:59:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-non-solo-pharma-limpatto-sulla-salute/ 2019-01-30T16:37:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-candidato-dengue-raggiunge-obiettivi-studio-di-fase/ 2019-01-30T16:57:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-2018-in-crescita-con-568-miliardi-di-chf-di-fatturato/ 2019-01-31T17:10:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pronta-per-la-brexit/ 2019-01-31T13:55:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-ok-fda-a-generico-advair/ 2019-01-31T17:13:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-group-il-ceo-lascia-a-marzo-e-calano-le-azioni/ 2019-01-31T14:46:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-q4-superiore-alle-stime/ 2019-01-31T16:05:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-lancia-test-genomici-per-il-cancro-al-super-bowl/ 2019-01-31T16:26:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nuovo-ok-del-nice-per-kymriah/ 2019-02-01T11:19:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-q4-sotto-le-previsioni/ 2019-02-01T11:51:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-investe-nella-terapia-genica-per-le-malattie-della-retina/ 2019-02-01T13:50:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-in-forte-aumento-le-vendite-di-ninlaro-ed-entyvio/ 2019-02-01T14:17:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-opzione-su-candidato-contro-amiloidosi/ 2019-02-01T15:15:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-pronto-nuovo-robot-per-la-chirurgia-vertebrale/ 2019-02-01T16:40:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/evolus-arriva-jeuveau-il-rivale-di-botox/ 2019-02-04T14:39:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-ok-chmp-per-ajovy/ 2019-02-04T18:32:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-vendite-record-per-keytruda/ 2019-02-04T17:46:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dr-reddy-forte-crescita-nei-mercati-emergenti/ 2019-02-04T15:29:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/siemens-healthineers-da-fda-ok-a-rm-infotainment/ 2019-02-04T16:38:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-al-via-12-studi-di-ricerca-indipendente/ 2019-02-04T17:11:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-punta-alla-diagnosi-precoce-del-tumore-del-polmone/ 2019-02-05T13:55:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-arriva-in-europa-nuova-lente-intraoculare-per-la-cataratta/ 2019-02-05T14:13:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-q4-in-ribasso-e-2019-flat/ 2019-02-05T15:34:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-a-milano-campagna-di-sensibilizzazione-sul-mieloma/ 2019-02-05T16:02:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/molmed-germania-conferma-rimborsabilita-zalmoxis/ 2019-02-05T16:20:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-cifra-monstre-per-immunoterapico-di-merck-kgaa-3-mld-di-euro/ 2019-02-05T17:08:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zentiva-il-calciatore-mimmo-criscito-nel-team-sport-ambassadors/ 2019-02-06T10:56:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-chiede-a-fda-estensione-indicazioni-kadcyla/ 2019-02-06T13:27:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-riduzione-dividenti-per-puntare-ad-acquisizioni-e-partnership/ 2019-02-06T13:51:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-il-fondo-appaloosa-marca-stretto-il-ceo-sauders/ 2019-02-06T14:08:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-breakthrough-therapy-e-prime-per-candidato-rsv/ 2019-02-06T15:59:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/colombo-country-director-facebook-italy-le-life-science-e-la-rivoluzione-digitale/ 2019-02-06T19:38:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-farmaceutici-diventa-una-societa-benefit/ 2019-02-06T17:53:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vas-narasimhan-ceo-novartis-in-usa-sconti-su-prezzi-ricadano-su-consumatori/ 2019-02-07T11:50:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-hemlibra-gratis-al-progetto-humanitarian-aid/ 2019-02-07T13:57:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-2019-sopra-le-stime-grazie-anche-a-shingrix/ 2019-02-07T14:34:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genentech-prende-i-diritti-della-pipeline-di-xencor/ 2019-02-07T16:35:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-crescita-dei-profitti-per-il-2019/ 2019-02-07T18:39:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-al-ted-per-un-nuova-idea-di-azienda/ 2019-02-07T17:23:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-punta-forte-su-truvada/ 2019-02-08T11:00:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-taglia-5-candidati-dalla-pipeline/ 2019-02-08T13:44:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-genzyme-nuove-prospettive-nellematologia-con-cablivi/ 2019-02-08T15:03:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-mylan-guerra-sul-brevetto-514-per-tecfidera/ 2019-02-08T14:42:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-al-via-nuovo-sistema-europeo-contro-la-contraffazione/ 2019-02-08T15:15:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-tar-pugliavietato-porre-in-concorrenza-nello-stesso-lotto-principi-attivi-differenti/ 2019-02-08T16:09:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/smith-nephew-su-nuvasive-per-tre-mld-di-dollari/ 2019-02-11T14:16:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-fda-estende-uso-dispositivo-per-aneurismi-cerebrali/ 2019-02-11T14:24:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-spot-in-tv-in-usa-con-i-prezzi-dei-farmaci/ 2019-02-11T14:42:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-senza-accordo-uk-fuori-dal-nuovo-sistema-contro-farmaci-contraffatti/ 2019-02-11T14:56:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boston-scientific-nuovo-device-per-lincontinenza-urinaria-maschile/ 2019-02-11T16:04:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-fuori-dal-tunnel-gli-analisti-ci-credono/ 2019-02-11T16:29:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-pfizer-nuova-affermazione-keytruda-inlyta-nel-tumore-del-rene/ 2019-02-12T11:22:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-italia-stefania-rinaldi-e-il-nuovo-diabetes-marketing-director/ 2019-02-12T11:42:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-esame-fda-per-esketamina-farmaco-intranasale-per-la-depressione/ 2019-02-12T11:54:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-nuovo-sistema-a-ultrasuoni-con-imaging-vascolare/ 2019-02-12T14:54:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-accordo-con-teneoone-per-anticorpo-bispecifico/ 2019-02-12T16:07:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-allarme-integratori-negli-usa/ 2019-02-12T17:05:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-italia-andrea-celli-nuovo-sales-e-operations-leader-entra-nel-cda/ 2019-02-13T17:10:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sun-pharmaceuticals-vola-quadruplicati-i-profitti-trimestrali/ 2019-02-13T17:39:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-ibm-in-canada-studio-clinico-con-il-metodo-blockchain/ 2019-02-13T15:43:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-governo-italiano-ricorre-alla-corte-di-giustizia-ue/ 2019-02-13T15:52:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-sconto-monstre-in-usa-per-il-generico-di-advair/ 2019-02-13T16:02:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-ventures-ex-ceo-agios-a-capo-delle-life-science/ 2020-11-10T09:01:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-e-fatta-per-auris-health/ 2019-02-14T13:21:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-arriva-il-chief-digital-officer/ 2019-02-14T14:39:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-oltre-le-previsioni-nel-q4/ 2019-02-14T15:03:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-a-clinigen-group-i-diritti-usa-di-proleukin/ 2019-02-14T15:20:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-cina-maxi-taglio-delliva-per-aprire-il-mercato/ 2019-02-14T15:49:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-vaccino-penumococcico-entra-nella-fase-clinica/ 2019-02-14T16:17:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fusione-widex-sivantos-nasce-colosso-dellaudiologia/ 2019-02-15T12:07:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-keytruda-al-via-tre-nuovi-studi/ 2019-02-15T18:10:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/convatec-2018-deludente-al-via-un-piano-di-risanamento/ 2019-02-15T14:41:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-accordo-con-abcellera-per-nuovi-anticorpi/ 2019-02-15T15:04:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/molmed-presentato-a-parigi-protocolla-terapia-car-t-cd44v6/ 2019-02-15T16:51:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-per-emgality-campagna-di-comunicazione-dtc/ 2019-02-15T17:37:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-bene-primo-studio-opdivo-candidato-nektar-in-tumore-vescica/ 2019-02-18T14:24:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-car-t-cms-usa-chiedono-la-copertura-medicare/ 2019-02-18T14:56:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-accordo-con-loxo-oncology-per-diritti-esclusivi-su-vitrakvi/ 2019-02-18T15:15:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-roche-120-mila-euro-per-sei-progetti-sullemofilia/ 2019-02-18T16:23:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-progetto-di-partnership-ospedaliera/ 2019-02-18T16:34:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-pfizer-combo-keytruda-inlyta-migliora-la-sopravvivenza-nel-cancro-del-rene/ 2019-02-18T17:10:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-celgene-sciolto-il-nodo-revlimid-nessun-generico-fino-al-2023/ 2019-02-19T10:18:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-entro-2019-generico-epipen-avra-un-quarto-del-mercato/ 2019-02-19T12:05:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-consumer-healthcare-lucia-strusi-a-capo-delle-hr-di-italia-grecia-e-israele/ 2019-02-19T17:42:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-il-nice-raccomanda-perjecta/ 2019-02-19T14:06:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-grandi-speranze-su-darolutamide-nel-cancro-alla-prostata/ 2019-02-19T16:12:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/md-fda-approva-pompa-insulinica-multidevice/ 2019-02-19T16:57:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-continuano-le-pressioni-del-fondo-appaloosa/ 2019-02-20T11:58:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-q4-2018-in-gran-salute-aumentano-le-previsioni-sugli-utili/ 2019-02-20T16:56:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-lilly-tanezumab-efficace-contro-il-dolore-da-osteoartrosi/ 2019-02-20T14:31:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/indivior-lancia-negli-usa-generico-del-suo-blockbuster-suboxone/ 2019-02-20T14:42:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chirurgica-mininvasiva-medtronic-acoi-al-via-il-programma-di-formazione-per-ernia-coloretto-e-bariatrica/ 2019-05-31T14:24:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intercept-studio-farmaco-contro-nash-raggiunge-endpoint-primario/ 2019-02-20T15:52:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fresenius-dopo-gli-investimenti-ripresa-della-crescita-nel-2020/ 2019-02-20T16:58:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/acqusizioni-il-risiko-2019/ 2019-02-21T12:05:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-lancia-pacemaker-per-epilessia/ 2019-02-21T12:34:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allogene-presto-un-impianto-usa-per-nuove-terapie-car-t/ 2019-02-21T13:24:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-a-breve-lancio-penne-per-insulina-multi-compatibili/ 2019-02-21T13:36:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-lhedge-fund-starboard-vuole-5-consiglieri-nel-cda/ 2019-02-21T17:34:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fresenius-ok-usa-a-fusione-con-nxstage-medical/ 2019-02-21T18:00:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-cede-unita-vaccini-indiana-a-bharat-biotech/ 2019-02-22T14:14:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-nuovo-acquisto-nellimmunoterapia-presa-immune-design/ 2019-02-22T14:35:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intuitive-surgical-ok-fda-a-robot-per-biopsie-polmonari/ 2019-02-22T14:59:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-via-libera-fda-per-esperoct/ 2019-02-22T15:21:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bausch-health-torna-a-crescere/ 2019-02-22T18:04:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shionogi-ce-autorizza-lusutrombopag-per-la-trombocitopenia/ 2019-02-22T16:13:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-131-mld-di-dollari-per-clementia-pharmaceuticals/ 2019-02-25T13:53:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-roche-acquista-spark-e-sua-per-43-mld-di-dollari/ 2019-02-25T14:18:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ionis-novartis-accordo-su-candidato-patologie-cardiovascolari/ 2019-02-25T15:16:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/icer-parere-positivo-alla-costo-efficacia-di-zolgensma-di-novartis/ 2019-02-25T15:47:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-e-voyager-laccordo-si-allarga-alla-ricerca-sul-parkinson/ 2019-02-25T16:58:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/universita-della-california-venclexta-funziona-nella-prevenzione-del-diabete/ 2019-02-25T17:11:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pasteur-triaxis-indicato-per-la-protezione-passiva-contro-la-pertosse/ 2019-02-26T12:04:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-allarme-lancet-con-o-senza-senza-accordo-impatto-drammatico/ 2019-02-26T15:01:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-a-danaher-lattivita-biopharma-per-214-mld-di-dollari/ 2019-02-26T18:41:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-lynparza-centra-obiettivo-studio-su-cancro-al-pancreas/ 2019-02-26T15:51:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-via-libera-al-primo-biosimilare-e-la-copia-di-rituxan/ 2019-02-26T16:53:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-linee-guida-per-i-device-del-futuro/ 2019-02-26T17:07:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/iniziano-i-lavori-della-giuria-dei-life-science-excellence-awards/ 2019-02-27T17:32:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-q4-sotto-le-stime-e-previsioni-in-ribasso-per-il-2019/ 2019-02-27T17:43:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-q4-2018-oltre-le-stime/ 2019-02-27T14:59:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-collaborazione-con-flatiron-sui-real-data-oncologici/ 2019-02-27T15:20:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leo-pharma-a-copenhagen-centro-di-eccellenza-per-ricerca-dermatologica/ 2019-02-27T15:59:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/porsche-consulting-ecco-la-pharma-40/ 2019-02-27T17:19:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-manovre-nellelettrochimica-nel-mirino-versum-materials/ 2019-02-28T13:52:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/caso-cohen-lex-pupillo-di-trump-tira-in-ballo-novartis/ 2019-02-28T14:31:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/curevac-accordo-con-cepi-per-nuova-tecnologia-di-produzione-vaccini/ 2019-02-28T14:46:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-italia-aderisce-a-millumino-di-meno/ 2019-02-28T15:03:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brand-valutation-pharma-crescita-in-doppia-cifra/ 2019-02-28T16:23:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-celgene-a-rischio-laccordo/ 2019-02-28T16:20:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-a-teatro-per-le-mici/ 2019-03-01T11:52:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-nuove-evidenze-su-tecfidera/ 2019-03-01T14:47:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/microsoft-e-takeda-ridurre-i-tempi-di-diagnosi-delle-malattie-rare/ 2019-03-01T15:00:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-ok-fda-ad-accurian-nel-trattamento-del-dolore-cronico/ 2019-03-01T15:11:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-opzione-su-candidati-tumore-polmone-di-biotech-scozzese/ 2019-03-01T16:31:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-europe-acido-bempedoico-allesame-di-chmp/ 2019-03-01T16:11:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-si-rafforza-nella-terapia-genica-con-nightstar-therapeutics/ 2019-03-04T13:49:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-verso-la-cessione-degli-otc/ 2019-03-04T14:05:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-pfizer-nuove-evidenze-per-combo-avelumab-axitinib-nel-rcc/ 2019-03-04T14:46:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-amplia-accordo-con-maxcyte-fino-a-10-obiettivi-car-t/ 2019-03-04T15:47:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-non-solo-appaloosa-cresce-il-fronte-anti-saunders/ 2019-03-04T15:55:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-darolutamide-riduce-del-59-il-rischio-di-metastasi-nel-tumore-della-prostata/ 2019-03-04T16:34:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-roche-al-via-la-quarta-edizione-di-roche-per-la-ricerca/ 2019-03-05T14:59:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-celgene-gli-analisti-dicono-si/ 2019-03-05T15:43:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-loffensiva-dei-generici-sui-blokbuster-a-scadenza-brevetto/ 2019-03-05T16:23:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-per-gli-usa-versione-economica-di-humalog/ 2019-03-05T16:21:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/open-aifa-switch-originator-biosimilari-nelle-malattie-reumatologiche-e-rare/ 2019-03-05T16:36:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-italia-due-concorsi-per-ricerca-scientifica-ed-associazioni-pazienti/ 2019-03-05T16:56:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-scott-gottlieb-si-e-dimesso/ 2019-03-06T14:41:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-revisione-prioritaria-fda-per-fedratinib/ 2019-03-06T14:54:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-lascia-alessandro-riva-leader-delloncologia/ 2019-03-06T15:06:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-arriva-spravato-antidepressivo-spray/ 2019-03-06T15:46:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/le-big-pharma-nellarena-della-psoriasi/ 2019-03-06T16:03:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-accordo-con-biotech-per-nuove-tecnologie-di-formulazione/ 2019-03-06T16:19:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-dek-chmp-a-risankizumab/ 2019-03-07T15:27:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-venture-amazon-berkshire-e-jpmorgan-si-chiamera-haven/ 2019-03-07T14:52:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-combo-di-insetticidi-contro-la-malaria-resistente/ 2019-03-07T15:00:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-utili-q4-in-ribasso-per-le-valute-estere/ 2019-03-07T15:26:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-italia-bollino-rosa-per-le-pari-opportunita/ 2019-03-07T17:08:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-rapastinel-fallisce-studi-fase-avanzata/ 2019-03-07T17:13:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-avanzata-richiesta-allema-per-darolutamide/ 2019-03-08T13:49:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-appaloosa-incalza-vuole-un-presidente-indipendente/ 2019-03-08T14:14:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aspen-per-ridurre-il-debito-split-del-business-pharma-in-sudafrica/ 2019-03-08T14:26:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boston-scientific-medtronic-testa-a-testa-su-valvola-cardiaca/ 2019-03-08T15:59:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ptc-therapeutics-italy-progetto-per-la-malattia-di-duchenne/ 2019-03-08T15:27:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-sguardo-hi-tech-sul-diabete/ 2019-03-08T15:58:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-ok-aifa-per-rivaroxaban-10-mg-per-nuovo-indicazione-terapeutica/ 2019-03-11T14:00:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/akili-e-shionogi-in-giappone-prima-terapia-digitale-per-ladhd/ 2019-03-11T14:08:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-nanofarmaco-per-trattare-il-diabete-di-tipo-1/ 2019-03-11T14:41:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-fda-per-tecentriq-nel-carcinoma-mammario-triplo-negativo/ 2019-03-11T14:57:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viiv-healthcare-efficace-combo-cabotegravir-rilpivirina-in-iniezione-mensile/ 2019-03-11T15:39:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-pronte-bozze-contratto-per-sperimentazione-clinica-farmaci-e-dm/ 2019-03-11T16:03:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-operativa-la-nuova-sede-di-amsterdam/ 2019-03-12T08:38:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-ninlaro-arriva-in-italia/ 2019-03-12T08:53:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ok-della-fda-a-biosimilare-di-herceptin/ 2019-03-12T11:51:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-sanofi-fda-estende-uso-dupixent-ad-adolescenti/ 2019-03-12T13:57:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibm-un-test-del-sangue-per-scovare-precocemente-lalzheimer/ 2019-03-12T14:34:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-celgene-nessun-piano-b/ 2019-03-12T16:29:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ned-sharpless-e-il-nuovo-direttore/ 2019-03-13T10:44:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-a-fujifilm-il-sito-produttivo-danese/ 2019-03-13T11:29:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-funziona-combo-cyramza-tarceva/ 2019-03-13T15:19:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/smith-nephew-prende-osiris-therapeutics/ 2019-03-13T15:37:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-ipo-entro-lanno-per-il-nasdaq/ 2019-03-13T16:23:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzo-farmaci-italia-chiede-a-oms-standard-internazionali-di-trasparenza/ 2019-03-13T16:29:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-tagli-ai-budget-sanita-ma-non-alla-fda/ 2019-03-14T10:47:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leucemie-il-4-aprile-torna-a-milano-una-mano-per-ail/ 2019-03-14T11:02:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-cosentyx-superiore-a-stelara-nello-studio-clarity/ 2019-03-14T11:32:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-ecco-i-vincitori-dellhack/ 2019-03-14T16:27:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/purdue-pharma-verso-il-fallimento/ 2019-03-14T15:27:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-pari-efficacia-tra-descovy-e-truvada-nella-prep/ 2019-03-14T15:51:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ce-approva-emicizumab-nella-profilassi-del-sanguinamento-emofilia-a/ 2019-03-15T07:22:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-italia-al-via-il-progetto-msd-crowdcaring/ 2019-03-15T14:40:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-lascia-il-ceo-richard-francis/ 2019-03-15T15:02:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/psorasi-in-usa-la-battaglia-del-marketing-si-combatte-in-tv/ 2019-03-15T15:31:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-un-nuovo-futuro-per-chantix/ 2019-03-15T15:48:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nash-corsa-alla-terapia-genfit-lancia-unipo-nasdaq/ 2019-03-15T16:02:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-crescono-fatturato-e-dipendenti/ 2019-03-18T11:30:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-pfizer-nuovi-dati-sulla-sicurezza-di-eliquis-in-pazienti-a-rischio/ 2019-03-18T14:24:36+00:00 monthly 0.2